• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 67 of 100
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
Finance
Here’s Why Valeant Selling Salix Was a Huge Surprise to the Stock Market
By Jen WiecznerNovember 1, 2016
Key Speakers At The Bloomberg Year Ahead 2015 Conference
Health
Mylan’s EpiPen Price Hikes Reportedly Add Millions to Pentagon Costs
By Reuters and Michelle TohOctober 28, 2016
Bayer Buys Monsanto
Finance
Bayer Beats Expectations with a Payoff in Profits
By Reuters and Michelle TohOctober 26, 2016
Most Powerful Women 2015
Health
This Could Be the Next Blockbuster Drug for GlaxoSmithKline
By ReutersOctober 24, 2016
Sanders Joins Clinton At Campaign Event In Portsmouth
Health
Bernie Sanders Butts Heads with Cancer Drug Maker over a Huge Price Hike
By Sy MukherjeeOctober 21, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
Why These Copycat Drugs Aren’t Slashing Best-Sellers’ Prices
By Sy MukherjeeOctober 18, 2016
How Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes
Health
How Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes
By Sy MukherjeeOctober 17, 2016
Mother sleeping with newborn baby on bed
Health
Homeopathic Treatments May Have Led to Deaths in Teething Babies
By Sy MukherjeeOctober 12, 2016
Novo Nordisk Chief Executive Officer Lars Soerensen Interview
Leadership
This Big Pharma Chief Was Just Named the World’s ‘Best-Performing’ CEO—Again
By Sy MukherjeeOctober 12, 2016
Cancer Consulting Elderly Person
Health
Why Pharma Giant Bristol-Myers Squibb’s Shares Took a Big Hit Today
By Sy MukherjeeOctober 10, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health
The FDA’s Most Controversial Drug Approval of the Year Just Hit a Huge Snag
By Sy MukherjeeOctober 7, 2016
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
Health
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
By Sy MukherjeeOctober 6, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
Health
Government Health Plans Spent Over $1 Billion on Mylan EpiPens Over 5 Years
By Fortune Editors and Reuters and Michelle TohOctober 6, 2016
CIO, 2 Others To Resign After JPMorgan Chase $2 Billion Trading Error
Retail
JPMorgan Is Pulling Chase ATMs from Walgreens Stores
By Reuters and Michelle TohOctober 4, 2016
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
Health
Samsung’s Biotech Unit Is Seeking Europe Approval for Its Copy of This Drug
By Reuters and Michelle TohOctober 3, 2016
1...
  • 65
  • 66
  • 67
  • 68
  • 69
...100
Most Popular
Success
Jeff Bezos once gave Eva Longoria and the admiral behind Osama bin Laden's capture $100 million—but she says you don't need wealth to give backplaceholder alt text
By Orianna Rosa RoyleOctober 31, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.